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Summary
Immunoglobulin A (IgA) deficiency (IgAD) is character-
ized by a defect of terminal lymphocyte differentiation,
leading to a lack of IgA in serum and mucosal secretions.
Familial clustering, variable population prevalence in
different ethnic groups, and a predominant inheritance
pattern suggest a strong genetic predisposition to IgAD.
The genetic susceptibility to IgAD is shared with a less
prevalent, but more profound, defect called “common
variable immunodeficiency” (CVID). Here we show an
increased allele sharing at 6p21 in affected members of
83 multiplex IgAD/CVID pedigrees and demonstrate,
using transmission/diseqilibrium tests, family-based as-
sociations indicating the presence of a predisposing lo-
cus, designated “IGAD1,” in the proximal part of the
major histocompatibility complex (MHC). The recur-
rence risk of IgAD was found to depend on the sex of
parents transmitting the defect: affected mothers were
more likely to produce offspring with IgAD than were
affected fathers. Carrier mothers but not carrier fathers
transmitted IGAD1 alleles more frequently to the af-
fected offspring than would be expected under random
segregation. The differential parent-of-origin penetrance
is proposed to reflect a maternal effect mediated by the
production of anti-IgA antibodies tentatively linked to
IGAD1. This is supported by higher frequency of anti-
IgA–positive females transmitting the disorder to chil-
dren, in comparison with female IgAD nontransmitters,
and by linkage data in the former group. Such patho-
genic mechanisms may be shared by other MHC-linked
complex traits associated with the production of specific
autoantibodies, parental effects, and a particular MHC
haplotype.
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Introduction
Selective immunoglobulin A (IgA) deficiency (IgAD
[MIM 137100]) is the most common primary immu-
nodeficiency (PID), with a prevalence of ∼1/600 in
whites. The affected individuals lack IgA in serum and
mucosal secretions and may suffer from frequent res-
piratory and gastrointestinal infections (for review, see
Burrows and Cooper 1997). A markedly differing pop-
ulation prevalence among ethnic groups (Burrows and
Cooper 1997), strong familial clustering of the disorder
(Koistinen 1976; Oen et al. 1982; Schaffer et al. 1989;
Vorˇechovsky´ et al. 1995), a predominant inheritance
pattern in multiple-case families that is compatible with
autosomal dominant transmission, and a high relative
risk for siblings (ls) (Vorˇechovsky´ et al. 1995) suggest
the involvement of thus-far-unidentified genetic factors
that are responsible for the deficient production of
isotypes.
Previous studies (Schaffer et al. 1989; Vorˇechovsky´ et
al. 1995) of close relatives of patients with IgAD suggest
a frequent occurrence of common variable immunode-
ficiency (CVID [MIM 240500]). This PID is more severe
than IgAD but is much less prevalent in the general pop-
ulation. Apart from IgA deficiency, CVID patients have
decreased levels of IgG and, often, IgM, resulting in fre-
quent infections. Our previous systematic study (Vorˇe-
chovsky´ et al. 1995) indicated a much higher than ex-
pected prevalence of CVID among close relatives of
patients with IgAD, suggesting a shared pathogenesis of
the two distinguishable PIDs. A substantial proportion
of families containing cases of both IgAD and CVIDwas
found in multiplex families obtained by screening for
serum Ig levels in family members of patients with IgAD
(Vorˇechovsky´ et al. 1995). In multiple-case families with
a dominant transmission of CVID/IgAD, CVIDwas usu-
ally present in the parental generation, followed by IgAD
in the descendants (Vorˇechovsky´ et al. 1995). This ob-
servation is consistent with the hypothesis that CVID
may develop later in life, as a more severe manifestation
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of a common, complex genetic defect, most likely in-
volving immunoglobulin class switching. This concept
is supported by a description of a gradual decline of
serum IgG levels that progresses at similar ages in af-
fected siblings (Johnson et al. 1997). Furthermore, IgG-
subclass deficiencies have been found in a subset of IgAD
patients (Oxelius et al. 1981). CVID may develop from
IgAD over time (Ishizaka et al. 1989; Espanol et al.
1996; Johnson et al. 1997), and, occasionally, vice versa
(Seligmann et al. 1991; Johnson et al. 1997). In both
diseases, anti-IgA antibodies can be detected. Because
(1) the disease phenotype is persistent (Koskinen et al.
1994; Vorˇechovsky´ et al. 1995), (2) the phenocopy rate
is low, and (3) ls, estimated at 50 (Vorˇechovsky´ et al.
1995), indicates a strong degree of familiar clustering,
chromosome susceptibility loci underlying this complex
trait should be detectable by genetic linkage analysis.
In recent years, advances in statistical methods for
linkage analysis, as well as the development of high-
density genetic maps, have facilitated the mapping of
predisposing loci for a number of polygenic and mul-
tifactorial diseases (Lander and Schork 1994; Dib et al.
1996). This methodology requires a well-defined and
sufficient collection of family material. In the present
study, we describe a large set of families with IgAD/
CVID, which was analyzed for genetic linkage and fam-
ily-based allelic associations at 6p21.3, containing the
major histocompatibility complex (MHC), a region pre-
viously implicated in case-control association studies
(Ambrus et al. 1977; Schaffer et al. 1989; Olerup et al.
1990; Volanakis et al. 1992). We also investigate both
a parental allele–transmission distortion discovered at
this locus and associated parent-of-origin differences in
the disease penetrance. It is proposed that the parental
transmission/penetrance bias is caused by a maternal ef-
fect involving the production of anti-IgA antibodies
found significantly more frequently in affected mothers
transmitting the defect to the offspring than in female
IgAD nontransmitters.
Subjects and Methods
Ascertainment of Probands and Their Offspring
Diagnosis of patients with IgAD and CVID was es-
tablished in accordance with accepted recommendations
(Burrows and Cooper 1997), on the basis of measure-
ments of Ig levels in multiple independent blood samples.
The identification of index cases has been described else-
where (Vorˇechovsky´ et al. 1995). Multiple-case families
were ascertained through the proband. In the offspring
analysis of male and female patients, the available rel-
atives of Swedish probands with either IgAD (64 females
and 52 males) or CVID (16 females and 7 males) were
contacted; all who responded and gave informed consent
were analyzed for serum Ig levels. Of 259 ascertained
children of affected parents, 14 were not available for
sampling. Approval to contact and sample family mem-
bers was obtained from local ethics committees.
Detection of Serum IgA and Anti-IgA Antibodies
Serum immunoglobulins were measured by routine
nephelometry (Hammarstro¨m et al. 1983). The meas-
urements were performed blind to family relationship
and affection status. When a multiple-case family was
found, the serum Ig measurements were repeated on an
independent sample from each family member, to con-
firm the affection status. The immunoglobulin measure-
ments of samples coming from outside Sweden were re-
peated in the Swedish laboratory, to guarantee that the
same method defined the phenotype. Such design also
ensured that a single sample could serve for both the
ascertainment of affection status and DNA extraction,
thus decreasing the probability of a laboratory mix-up.
Anti-IgA antibodies were detected with an ELISA assay,
as described elsewhere (Hammarstro¨m et al. 1983).
Analysis of Families for Genetic Linkage and Allelic
Association
Multiple-case families were collected in Sweden
( ), the United Kingdom ( ), and Italyn  47 n  21
( ). In addition, samples from small multiple-casen  4
families were obtained from the Netherlands ( ),n  2
the Czech Republic ( ), Turkey ( ), Finlandn  2 n  1
( ), Poland ( ), and Spain ( ). The com-n  2 n  1 n  2
plete pedigree structure of multiple-case families used
for nonparametric genetic linkage analysis is shown at
a Website of the Karolinska Institutet Department of
Biosciences at NOVUM. The families with multiple sibs
contained 59 affected sib pairs and 4 affected sib trios;
two families had 4 affected siblings each. Both parental
samples for affected siblings were available from 37 fam-
ilies, a single parental sample in 15 families, and no
parental sample in 13 families. Of 83 multiple-case fam-
ilies, 48 had only IgAD, 10 families had only CVID, and
25 families (30%) included both IgAD-affectedmembers
and CVID-affected members. Among the 25 families
with both diseases, 19 were multigenerational; in 16
there was a patient with CVID in the parental genera-
tion, followed by IgAD in a subsequent generation. Bil-
ineal multiple-case families, rare cases with previously
found homozygous deletions in the immunoglobulin
structural genes (Plebani et al. 1993), and those with
drug-induced IgAD (Truedsson et al. 1995) were not
included in the study. Transmitting parents were defined
as subjects who had affected offspring who themselves
were affected. The family material used for the trans-
mission/disequilibrium test (TDT), consisting of Swedish
and U.K. sporadic cases with unaffected parents (and of
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Table 1
Results of TDTassoc and TDTlink for IgAD/CVID Families
MARKER
LOCUSa vb
NO.
(SIZE [bp])/
FREQUENCY
OF ALLELE
T/NT
FOR
TDTassoc P/MGRR
c
T/NT, FORd P, FOR
TDTplink TDTmlink TDTalllink TDTp/TDTm/TDTall
c TDTalle
D6S461 .04 NS NS
D6S1621 .005 4 (290)/.227 53/34 .042/4.1 21/18 28/17 60/42 .37/.068/.075 .224
D6S1558 .005 7 (248)/.596 62/40 .029/4.7 29/26 30/18 72/45 .39/.056/.0126 .038
D6S273 .03 1 (140)/.132 35/14 .0027/9.0 15/12 18/4 40/16 .35/.002/.0013 .0039
D6S1583 .03 NS NS
D6S291 .04 1 (212)/.103
3 (206)/.042
28/13
13/5
.019/5.5
.059/3.6
12/10
6/4
16/5
9/2
32/16
15/8
.42/.013/.021
.38/.033/.144
.063
.43
D6S1610 ) NS NS
NOTE.—Allelic frequencies were estimated from the sample of 253 pedigree members without parents (founders and married-ins).
The genetic map and v values are as published elsewhere (Dib et al. 1996) and correspond to those estimated from the pedigree data
by the MLINK and ILINK options of the LINKAGE pedigree package (version 5.1). The TDT algorithm as incorporated in the
extended TDT (Sham and Curtis 1995) was applied to TDTassoc and TDTalllink, whereas the GAS asstdt module, which does not
deduce incomplete parental genotypes and avoids a potential parental bias, was used for TDTplink and TDTmlink. The weighted option
of the TDT (GAS) yielded comparable P values. The Bonferroni correction, which is likely to be conservative for ETDT (Sham and
Curtis 1995), was used for presenting corrected P values.
a Listed in order, from telomere to centromere.
b Value shown is that between the marker and that in the row immediately below.
c NS  not transmitted significantly more frequently than would be expected by chance.
d TDTplink  paternally derived alleles, TDTmlink  maternally derived alleles, and TDTall all transmitted/non-transmitted alleles
from heterozygous parents.
e Data are corrected P values.
affected sib pairs with unaffected parents, in the TDT
as a test of linkage), is shown at a Website of the Ka-
rolinska Institutet Department of Biosciences at
NOVUM.
There was no overlap between the range of serum IgA
level found in unaffected and affected family members,
except for three families with IgAD that were excluded
from the study. Therefore, the phenotype was considered
as a categorical trait defined by serum IgA levels found
repeatedly to be lower than a detection limit of 0.05 g/
liter (Burrows and Cooper 1997). In addition, IgA levels
obtained from two measurements on two independent
samples were also analyzed as a quantitative-trait locus
(QTL). The means of IgA levels (g/liter) for each family
member are shown at a Website of the Karolinska In-
stitutet Department of Biosciences at NOVUM.
DNA was extracted from blood samples, by routine
techniques. Polymorphic markers, estimates of their ge-
netic distances, and the frequencies of associated alleles
are shown in table 1. Typing was performed with fluo-
rescent-labeled primers (Research Genetics), on an ABI
373A-Stretch DNA Sequencer with GENESCAN 672
and GENOTYPER software packages (Applied Biosys-
tems–Perkin-Elmer). Allelic sizes were converted to allele
numbers by the GAS program (A. Young, University of
Oxford), and the accuracy of conversion was checked
manually. A strict global binning of allele sizes was ap-
plied throughout the study. Genotypes of family mem-
bers are available at the indicated Websites.
The TDT (Spielman et al. 1993; Schaid and Sommer
1994; Sham and Curtis 1995; Spielman and Ewens
1996) was used as a test for genetic linkage (TDTlink),
both in single-case families with unaffected parents and
in multiple-case families each containing two or more
affected sibs with unaffected parents. As a test of allelic
association (TDTassoc), the TDT was applied only to the
firstborn affected individual in multiple-case families and
in “single case–father–mother” trios (Spielman and Ew-
ens 1996). To reduce the problem of multiple testing,
the three most common alleles at each locus were ana-
lyzed by the TDT. The nonparametric linkage (NPL)
(Kruglyak et al. 1996) andZ statistics (Lange 1986)were
computed with the software packages GENEHUNTER
(version 1.1) and GAS (version 2.0), respectively. The
GENEHUNTER-PLUS program, which incorporates a
one-parameter allele-sharing model (Kong and Cox
1997), was used to generate Zlr and LOD* scores. The
QTL statistics were analyzed by the GAS modules
sibmwu, assmwu (Mann-Whitney U tests for sib-pair
analysis and association, respectively), and sibhe (Has-
eman-Elston multipoint-regression algorithm).
Results
Allelic Associations and Genetic Linkage of IgAD/CVID
at 6p21.3
To exclude the possibility that allelic associations in
the MHC region in previously reported case-control
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Table 2
Transmission of Associated Alleles in 96 Genotyped Control Child-
Father-Mother Trios
MARKER
LOCUS v
NO. (SIZE [bp])
OF ALLELE
T/NT, FOR
PTDTp TDTm TDTall
D6S1621 .005 4 (290) 17/14 14/13 31/26 NS
D6S1558 .005 7 (248) 19/16 24/18 43/34 NS
D6S273 .06 1 (140) 9/8 8/8 17/16 NS
D6S291 1 (212) 8/8 10/9 18/17 NS
3 (206) 6/5 4/5 10/10 NS
NOTE.—Data are as explained in the footnotes to table 1.
studies (Ambrus et al. 1977; Olerup et al. 1990; Volan-
akis et al. 1992) were caused by a population-structure
effect and did not reflect genuine linkage disequilibrium,
nontransmitted parental genotypes were used as internal
controls in the TDTassoc. A total of 126 unrelated patients
(83 with IgAD and 43 with CVID) with either both
parents unaffected ( ) or only one parent unaf-n  224
fected ( ) and the second parental sample missingn  14
were genotyped with microsatellite markers covering
14 cM at and around the MHC region (table 1). The
TDTassoc showed that the 140-bp allele at D6S273 was
transmitted from heterozygous parents to the affected
offspring more often than would be expected by chance
(35 transmissions [T] vs. 14 nontransmissions [NT]).
The corresponding matched–genotype relative risk sta-
tistic (MGRR) (Schaid and Sommer 1994), was 9.0
( ). The x2 for allelewise-extended TDTP  .0027
(ETDT, version 1.8; Sham and Curtis 1995) at D6S273
was 15.0 (7 df, ). Weaker transmission dise-P  .036
quilibria andMGRRs were observed at linked loci (table
1). Apart from Swedish and U.K. families, the trans-
mission bias was found in 21 single-case families of
northern Italian ancestry (7 T vs. 1 NT of the 140-bp
allele at D6S273 [ ]).P ! .05
The TDT was also used as a test of linkage in the
presence of allelic association (Spielman and Ewens
1996) in 146 affected individuals (100 with IgAD and
46 with CVID, including multiple affected sibs) with
unaffected parents. The TDTlink was positive forD6S273
(the x2 for allelewise ETDT was 15.1, 7 df, ),P  .035
with detectable transmission bias at flanking marker
loci, indicating that allelic associations are indeed caused
by the presence of a disease-susceptibility gene(s)/mu-
tation(s) (termed “IGAD1”) in the corresponding ge-
nomic region. In addition to alleles with an excess of T
over NT (table 1), allele 9 (244 bp) at D6S1558 and
allele 4 (134 bp) at D6S273 were preferentially retained
in heterozygous parents (15 T vs. 33 NT [ ] andP  .009
40 T vs. 59 NT [ ], respectively). The analysis ofP  .05
control DNA samples from 96 child-father-mother trios,
ascertained through a child with either cystic fibrosis or
phenylketonuria, both of which are recessive diseases
mapping to different chromosomes and are not expected
to show an allele transmission disequilibrium at 6p21,
revealed no segregation bias for any marker alleles (table
2).
The TDT results were consistent with the nonpara-
metric genetic linkage analysis of 83 multiplex IgAD/
CVID pedigrees containing a total of 449 individuals
(215 affected, 178 nonaffected, and 56 with unknown
phenotypes). The results of single-point NPL analysis of
all sib-pairs by the GENEHUNTER program are shown
in table 3. The maximum single-point NPL score was
2.63 ( ) at D6S1583 (table 3). NPL scores atP  .001
flanking centromeric loci and telomeric D6S273 were
also significant (table 3). In the multipoint GENE-
HUNTER analysis, the maximum NPL score was 2.4
( ; proportion of IGAD1-linked families [a] .40,P  .003
information content .83) between D6S1583 and
D6S291. The GENEHUNTER-PLUS program, which
computes Zlr and LOD* scores under a one-parameter
allele-sharing model, to eliminate the conservativeness
of NPL if the identity-by-descent information is less com-
plete, gave a maximum Zlr of 2.84 and LOD* of 1.75,
in the same region. Similarly, the identity-by-state (IBS)
sib-pair analysis (Lange 1986) revealed significant allelic
sharing at the same marker loci, comparable with that
shown by the NPL analysis (table 3).
Although there was no overlap, in serum IgA levels,
between IgAD and unaffected individuals in any family
included in the linkage study, the mean serum IgA levels
in family members were also analyzed as a QTL. In
accordance with single-point analysis of IgAD as a cat-
egorical trait, the sib-pair analysis with the Mann-Whit-
ney U-test showed the strongest QTL sharing at
D6S1583 and also showed significant allele sharing at
flanking loci (data not shown). The test also confirmed
both a significant positive association ( ) be-P ! .0001
tween the 140-bp allele at D6S273 and low levels of
IgA and significant negative association ( ) be-P ! .0005
tween the 134-bp allele and low levels of IgA, indicating
a protective effect. The Haseman-Elston multipoint-re-
gression analysis on weighted sib pairs showed maxi-
mum sharing closer to D6S291, an area ∼2 cM cen-
tromeric to that obtained by multipoint NPL analysis.
IgAD versus CVID
In separate association analyses of IgAD and CVID,
the TDTassoc was positive for IgAD (25 T vs. 8 NT of
the 140-bp allele at D6S273 [ ] and 19 T vs. 8P  .003
NT of 212-bp allele at D6S291 [ ], based on 83P  .03
affected offspring with 158 unaffected parents and 8
parents with unknown phenotype) but not for CVID (10
T vs. 6 NT, based on 43 affected individuals with 79
unaffected parents and 7 parents with unknown phe-
notype). Although TDT that was performed on all sub-
jects with IgAD/CVID did not show a statistically sig-
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Table 3
Single-Point IBS and NPL Analysis for 6p21.3 Markers and IgAD/CVID
MARKER
LOCUS v
IBS SHARING NPL ANALYSIS
No. of
Affected
Sib Pairs
2-1-0 Sharing
(Observed/Expected)
One-Sided P
for Affected
Sib Pairs
Total No. of
Sib Pairs
One-Sided
P for All
Sib Pairs
NPLall (P/
Information Content) Zlr LOD*
D6S461 .04 66 26.5-33.5-6.0/25.1-34.2-6.7 .35 85 .23 .65 (.23/.59) 1.01 .222
D6S1621 .005 64 29.3-31.0-3.7/27.0-31.9-5.0 .23 85 .22 .31 (.36/.54) .48 .051
D6S1558 .005 68 37.5-25.5-5.0/34.4-30.1-3.5 .38 89 .16 .07 (.47/.46) .12 .029
D6S273 .03 68 30.8-32.8-4.3/24.9-35.7-7.4 .044 89 .026 1.62 (.032/.64) 2.36 1.21
D6S1583 .03 67 33.7-28.7-4.7/22.6-35.6-8.8 .0024 87 .0043 2.63 (.001/.71) 3.45 2.58
D6S291 .04 69 41.5-23.2-4.3/29.8-34.1-5.1 .0074 89 .022 1.72 (.025/.52) 2.73 1.623
D6S1610 65 32.8-24.8-7.3/24.3-34.0-6.7 .061 84 .17 1.61 (.033/.59) 2.18 1.033
nificant transmission disequilibrium at D6S1583, the
separate analysis of only the families with IgAD did
show a weak transmission distortion of a 191-bp allele
(30 T vs. 16 NT [ ]). In addition, the 133-bp alleleP  .04
at D6S1610 showed 32 T from heterozygous parents,
although on 18 occasions it was not passed on to the
offspring who had IgAD ( ); the same allele alsoP  .047
showed a positive QTL U-test association ( ).P  .027
Similarly, TDTlink was positive for IgAD only. The
analysis of a total of 267 individuals in 84 families with
100 IgAD patients showed 30 T versus 10 NT of the
140-bp allele at D6S273 ( ) and 23 T versusP  .0016
10 NT of the 212-bp allele at D6S291 ( ). InP  .024
CVID, however, there was a tendency of the frequent,
248-bp allele at D6S1558 to be transmitted to the off-
spring more often than expected (24 T vs. 14 NT).
Parental Differences in Segregation of Associated
Alleles at IGAD1
The TDTlink showed that, at D6S273 and flanking
markers, the transmission of IgAD-associated alleles
from unaffected heterozygous mothers to the affected
offspring was significantly in excess of what would be
expected by chance; alleles transmitted from unaffected
heterozygous fathers exhibited random segregation at
these loci (table 1). Both allelewise ETDT and genoty-
pewise ETDT (Sham and Curtis 1995) were positive for
maternally transmitted alleles at D6S273 ( , 72x  20.8
df, ,P  .004 P [standard error {SE}] .0050m
and , 19 df, ,2.0022 x  36.3 P  .010 P  .0340m
, respectively, where Pm is the empirical P value.0057
obtained by Monte Carlo simulations with the
MCETDT program, version 1.2 (J. Zhao, D. Curtis, and
P. Sham; see the University College London on-line site
listed in the Electronic-Database Information section)
and at D6S291 ( , 7 df, ,2x  18.4 P  .01 P m
and , 14 df, ,2.0100 .0031 x  25.6 P  .03 P m
, respectively). AtD6S1558, a similar ten-.0600 .0075
dency was found ( , 7 df, and2 2x  14.6 P  .067 x 
, 16 df, , respectively), although neither al-24.4 P  .08
lelewise ETDT nor genotypewise ETDT was significant
for paternally transmitted alleles. The observed differ-
ence between parental transmissions was significant for
the 140-bp allele at the D6S273 locus (GAS TDT al-
gorithm, Fisher’s exact test, ). The sex of affectedP ! .05
recipients of this allele was equally represented.
In contrast, neither maternal nor paternal transmis-
sion distortion was observed by typing of 96 unaffected
control probands and their biological parents, ascer-
tained through the index case with an unlinked recessive
disease (table 2). Because the 140-bp allele at D6S273
was found to be on the B8-DR3 haplotype, previously
associated with IgAD (Ambrus et al. 1977; Schaffer et
al. 1989; Olerup et al. 1990) and a number of auto-
immune diseases, we also analyzed child-father-mother
trios, for a possible segregation bias of this haplotype.
These trios were selected from a large sample of children
and both parents, which previously had been typed, for
MHC specificities, at the Huddinge Hospital. The survey
of several hundred consecutively typed index cases re-
vealed 38 heterozygous B8-DR3 carriers (17 females and
21 males) with heterozygous parental haplotypes. All 38
index cases were free of IgAD/CVID, as documented by
normal serum Ig measurements. Eighteen individuals in-
herited the B8-DR3 haplotype from heterozygous moth-
ers, 20 from heterozygous fathers ( ).P 1 .05
Because there was no parental transmission bias of
microsatellite alleles/MHC haplotypes, either in unaf-
fected controls or in previous studies of the MHC in
unaffected individuals (Klitz et al. 1987), we conclude
that the parental allele segregation distortion was con-
fined to the IgAD phenotype. This indicates that the
contributions that parental haplotypes at IGAD1 make
to the development of the disorder are not equal. One
explanation for this finding is putative paternal gametic
imprinting at the IGAD1 locus, which is supported by
the structure of some pedigrees with IgAD. In four as-
certained large, multigeneration pedigrees with IgAD
skipping one generation, it was always a nonmanifesting
woman who transmitted the phenotype to the offspring
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Table 4
Number of Female/Males, as Index Cases in Reported Multiple-Case Families with IgAD/CVID, as Parents Transmitting the Disease to Their
Offspring, and as Children of Transmitting Parents
SOURCE
NO. OF FEMALES/MALESa
NO. OF AFFECTED
CHILDREN OF FEMALES/
MALES WITH IgADa
Index
Cases
Transmitting
IgAD
Ammann and Hong (1971) ?/? 2/1 3/1
de Asis et al. (1996) 1/0 1/0 2/0
Bach et al. (1971) 1/0 0/1 0/2
Beermann and Holm (1974) 1/0 1/0 2/0
Buckley (1975) 1/1 1/1 1/1
Cleland and Bell (1978) 1/0 2/0 10/0
Cuccia-Belvedere et al. (1989) ?/? 4/1 ?/?
Cunningham-Rundles et al. (1991) 2/1 3/1 4/1
Douglas et al. (1971) 1/0 1/0 1/0
Gudmundsson and Jensson (1977) 0/1 1/0 1/0
Hilman et al. (1969) 1/0 1/0 2/0
Hobbs (1968) 1/3 2/2 4/2
Huntley and Stephenson (1968) 3/1 2/1 3/1
Kirkpatrick and Ruth (1966) 1/0 1/0 1/0
Koistinen (1976), S. Koskinen (personal communication) 6/6 3/5 5/7
de Laat et al. (1991) 2/0 2/0 2/0
Lakhanpal et al. (1988) 1/0 2/1 4/1
Lawton et al. (1972) ?/? 0/1 0/1
Levitt and Cooper (1981) 1/0 1/0 2/0
van Loghem (1974) 1/0 1/0 6/0
Natvig et al. (1971) 1/0 1/0 1/0
Nell et al. (1972) 1/2 2/1 3/1
Oen et al. (1982) 3/4 5/3 14/3
Rosner et al. (1978) 1/0 0/1 0/1
Schwartz et al. (1969) 0/1 0/1 0/2
Stocker et al. (1968) 1/0 2/0 3/0
Tomkin et al. (1971) 1/0 1/0 2/0
Vassalo et al. (1970) 0/1 2/1 5/1
Volanakis et al. (1992) 0/1 1/4 1/5
a A question mark (?) denotes that the relevant numbers could not be obtained from the reference.
(data not shown). In addition, a survey of published
multiple-case pedigrees with IgAD/CVID (table 4) also
showed two such pedigrees (family 50 in a study by Oen
et al. [1982] and family 15 in a study by Volanakis et
al. [1992]). These pedigrees had been proposed as being
indicative of paternal gametic imprinting in a disease-
predisposing locus (Hall 1990). Direct testing of this
hypothesis, however, awaits the identification of the sus-
ceptibility-gene(s)/mutation(s) at IGAD1.
Penetrance of IgAD in the Offspring: Dependence on
Gender of Transmitting Parent
If there is a parental allele transmission bias at
IGAD1, and if this locus contributes substantially to the
IgAD susceptibility, then one should see parent-of-origin
penetrance differences in families. We therefore studied
the offspring of Swedish index cases and individuals
transmitting the disease to the next generation. A total
of 87 women with either IgAD or CVID as index cases
gave birth to 159 offspring, and a total of 52 affected
men as index cases produced 86 offspring; 32 (20.1%)
of the children born to affected women were found to
be affected, whereas only 5 (5.8%) of the children born
to affected men had IgAD ( ). To address theP ! .005
possibility that the ascertainment of paternal descen-
dants was less complete, the offspring of an additional
26 male patients with IgAD were screened for serum Ig
levels. In 42 analyzed children, only a single case of IgAD
was identified.
This differential disease recurrence risk for children of
women index cases versus children of men index cases
was consistent with previous reports of multiple-case
pedigrees, in which the total number of affected off-
spring of women with IgAD was much higher than the
total number of affected offspring of men with IgAD
(table 4). Although the numbers of men and women as
index cases of multiplex families published to date are
similar (28 vs. 23, respectively), which is consistent with
the approximately equal sex ratio of our probands, the
number of female patients transmitting the disease was
higher than the number of affected male transmitters (45
vs. 26). The survey of multiplex pedigrees in 29 pub-
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Table 5
Prospective Follow-up of Children of Affected Females with
Documented Anti-IgA Antibody Titers during Pregnancy
PATIENTa
STATUSb
Maternal Anti-IgA/
First Child (age [years])
Maternal Anti-IgA/
Second Child (age [years])
1 /IgAD (11) /NA (8)
2 /NA (15) /NA (13)
3 /NA (12)
4 /NA (8) /NA (6)
5 /NA (8)
6 /IgAD (12)
7 /NA (8) /NA (3)
8 /NA (10) /NA (5)
9 /IgAD (9) /IgAD (7)
10 /NA (13) /NA (7)
11 /NA (2)
12 /IgAD (6)
a Patients 10 and 11 had CVID; the remaining patients had IgAD.
b Titers are represented as follows:   1:64;   1:256;
  1:1,024;   11,024. NA  not affected.
lished reports (table 4) also showed that, although the
affected women gave birth to a total of 82 children with
IgAD, only 30 affected children of male transmitters
were ascertained. The total numbers of affected children
of women and men with IgAD, including those in the
Swedish data set, were 123 and 46, respectively, indi-
cating that mothers with IgAD are more likely to trans-
mit the defect to their offspring than are the affected
fathers. This difference could be explained by several
factors, including ascertainment bias, feto-maternal in-
teractions, and paternal genomic imprinting at one or
more IgAD/CVID-susceptibility loci.
Serum Anti-IgA Antibodies: More Prevalent in Females
Transmitting IgAD than in Nontransmitters
To assess a possible maternal effect exerted by IgG
autoantibodies in disease susceptibility (Petty et al.
1985), we analyzed the frequency of carriers with anti-
IgA antibodies in Swedish single- and multiple-case fam-
ilies. The overall frequency of Swedish IgAD patients
without a family history of IgAD/CVID who were pos-
itive for anti-IgA antibodies (anti-IgA) was 22.2% (36/
162 tested). Anti-IgA females with IgAD (20/88 tested)
and anti-IgA males with IgAD (16/74 tested) were
equally represented (22.7 vs. 21.6%; ). In con-P 1 .05
trast, 22 (20 with IgAD and 2 with CVID) of 36 affected
females (31 with IgAD and 5 with CVID) transmitting
the disease were anti-IgA ( for females,2x  17.9 P !
). This difference remained significant when only.00005
women with anti-IgA IgAD who do not have a family
history of IgAD/CVID and who gave birth to unaffected
offspring (8/37 tested) were considered versus those with
affected offspring (20/31 tested; , ).2x  12.8 P ! .0005
Although the presence of anti-IgA antibodies in mothers
with IgAD could theoretically be attributed to previous
therapy with IgA-containing gammaglobulin prepara-
tions, only 1/20 mothers with IgAD anti-IgA had been
treated.
Even though the production of anti-IgA antibodies
observed in a subset of IgAD is considered to be a con-
stant feature over many years (Koskinen et al. 1995),
antibodies may occasionally disappear or diminish in
titer in mothers after delivery (Petty et al. 1985). There-
fore, serum IgA levels were analyzed prospectively in the
offspring of those women with IgAD/CVID who had
been examined for anti-IgA antibodies during their preg-
nancies. Our 15-year follow-up of children of 12 such
mothers with IgAD (4 with anti-IgA- and 8 with anti-
IgA) showed (table 5) that 0/8 children born to mothers
who were negative for IgAD developed IgAD, although
5/11 children born to mothers with anti-IgA have IgAD
( , Fisher’s exact test). The mean age of the off-P  .04
spring at the time of sampling for serum Ig levels was
similar in the two groups (9.4 and 7.5 years, respectively;
, t-test). These observations indicate that womenP  .26
with IgAD who have affected children are more likely
to develop anti-IgA antibodies than are IgAD-nontrans-
mitting mothers, and our prospective study suggests that
pregnant women with anti-IgA and IgAD tend to pro-
duce more affected descendants than are produced by
affected mothers with no detectable anti-IgA antibodies
during pregnancy. This supports a role for specific au-
toantibodies in the familial clustering and pathogenesis
of IgAD.
Disease Susceptibility Conferred by IGAD1:
Involvement of an Autoimmune Component Mediated
by Anti-IgA Antibodies
To investigate whether the evidence for linkage to
IGAD1 was greater in multiplex families with women
with both anti-IgA and IgAD who transmitted the dis-
ease to their offspring than it was in the remaining dom-
inant families—in which either the transmitting women
were anti-IgA, the transmitters were men, or the au-
toantibody status was unknown—separate NPL analy-
ses were performed. At D6S273, the NPL score was
1.620 ( ; LOD score 1.095, , informationP  .02 a  .96
content .64) in the former group, consisting of 20 fam-
ilies with anti-IgA, suggesting a linkage to this marker.
In contrast, the latter group of 31 pedigrees had an NPL
score of .143 ( , LOD score -4.843, ,P  .42 a  .002
information content .64), giving no evidence for linkage.
Similar differences between the two groups were ob-
served for other markers in the region (data not shown).
These results are not inconsistent with our previous anal-
ysis of a subset of 16 dominant families exhibiting no
evidence for linkage at 6p21 (Vorˇechovsky´ et al. 1995):
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only 4 of these families were later found to have anti-
IgA transmitting women, whereas the remaining ped-
igrees had anti-IgA or male transmitters. These results
strongly support genetic heterogeneity of IgAD/CVID,
which was, in addition to a small sample size, likely to
have contributed to previous negative linkage data. They
also show that the predisposition to IgAD in families
with females who are anti-IgA transmitters is likely to
be determined, to large extent, by IGAD1. This locus
thus confers susceptibility to the development of anti-
IgA antibodies and appears to be a major contributor
to parental penetrance effects.
Discussion
Parent-of-Origin Penetrance Differences in IgAD
This report is the first formal demonstration of the
differential parent-of-origin penetrance in the offspring
of IgAD patients. Previously, Oen et al. (1982) had no-
ticed a higher number of affected children born to moth-
ers with IgAD, compared with the number of affected
children born to affected fathers, in one large multiple-
case family. Petty et al. (1985) analyzed serum IgA levels
in infants and small children at age 2–29 mo who had
been born to an affected parent, and they observed that
the offspring of mothers with IgAD—but not the off-
spring of fathers with IgAD—had mean levels of serum
IgA that were below normal values. We had considered
parental penetrance effects to be due to the ascertain-
ment bias in probands. First, female index cases iden-
tified through the clinical chemistry department were
overrepresented (Vorˇechovsky´ et al. 1995) because
women either were referred to or sought a routine check-
up for serum Ig levels more often than men did. How-
ever, affected women ascertained by this referral route
were not overrepresented among those transmitting the
disease to the offspring, nor did they contribute sub-
stantially to the number of probands (Vorˇechovsky´ et
al. 1995). Furthermore, the ascertainment of large num-
bers of cases by the screening of either infection-prone
individuals or the general population yielded approxi-
mately equal sex ratios (Vorˇechovsky´ et al. 1995), con-
sistent with a vast body of data in the literature (Petty
et al. 1985; Truedsson et al. 1995; Burrows and Cooper
1997). Second, the ascertainment of the offspring of af-
fected men may have been less complete than the as-
certainment of the offspring of affected women. Meas-
urements of serum Ig levels in 42 descendants of
additional men with IgAD, however, yielded a similar
estimate of the recurrence risk for men, 1/42 versus 5/
86 ( ); both of these estimates are significantlyP 1 .05
lower than the ∼1/5 recurrence risk for descendants of
women with IgAD. Third, because the exact age-depen-
dent penetrance is unknown for IgAD, the transmission
bias may be explained by an earlier date of birth of
children of female transmitters. However, there was no
significant difference between the mean ages of female
versus male transmitters in our sample. Fourth, parental
effects can be seen in a single family with many affected
individuals (Oen et al. 1982; Schroeder et al. 1998).
Most important, a possible bias in the proband ascer-
tainment cannot account for the clear evidence of pa-
rental allele transmission distortion observed at IGAD1
(table 1), because only unaffected parents of sporadic
cases/affected sib pairs were analyzed in the TDT.
The penetrance bias may also result from reduced fer-
tility in men with IgAD, compared with that in women
with IgAD. This seems to be supported by a maximum
allele sharing in the region syntenic to the t-complex in
mice (Dunn 1957; Ardlie and Silver 1996). Mouse t-
haplotypes are variants of the proximal third of chro-
mosome 17 that are known by their capacity for seg-
regation distortion and a 50–100-fold reduction in nor-
mal levels of recombination (Ardlie and Silver 1996).
Although their segregation in females is consistent with
Mendelian ratios, t/ heterozygous males transmit the
t-haplotypes to 195% of their offspring, although ho-
mozygous t/t males are sterile, preventing a fixation of
t-haplotypes in the population (Dunn 1957; Ardlie and
Silver 1996). However, in our study, although the total
number of ascertained offspring of men with IgAD was
somewhat lower than that of women with IgAD, a sig-
nificant difference was observed only for the affected
offspring. The segregation of the IgAD-associated B8-
DR3 haplotype, in which recombination is suppressed
relative to that for other haplotypes (Thomsen et al.
1994), as well as the segregation of IgAD-associated mi-
crosatellite alleles and HLA specificities (Klitz et al.
1987), did not depart from Mendelian ratios in unaf-
fected individuals, arguing against a “meiotic drive” in
controls. At a large number of polymorphic loci
throughout the genome, no apparent inheritance errors
have been noted in any of the 83 families included in
the linkage study, (I. Vorˇechovsky´, unpublished data).
The possibility that the transmission of some IgAD/
CVID-associatedMHC haplotypes to the unaffected off-
spring may still be distorted will need to be addressed
in future studies, after the identification of IGAD1.
With a small number of families, the extended B8-DR3
haplotypes containing the GLO2 allele—but not
GLO1—were reported to exhibit an excess transmission
from men but not from women (Awdeh et al. 1983).
The inheritance pattern of IgAD/CVID, with a pre-
dominance of maternal transmission and different in-
trafamilial phenotypic manifestations, is reminiscent of
that of mitochondrial defect(s). However, although pa-
ternal mitochondrial inheritance has been described in
experimental populations (Gyllensten et al. 1991; Zou-
ros et al. 1992), it is considered rare in humans, and
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there have been few, if any, documented cases of human
paternal transmission of mitochondria that has resulted
in a disease (Schork and Guo 1993). The existence of a
number of affected father-child pairs observed among
our IgAD/CVID patients does not support this hypoth-
esis; however, this argument weakens for human com-
plex traits compared with Mendelian diseases, particu-
larly if mitochondrial and nuclear gene products
interact.
A number of human phenotypes have been shown to
exhibit differential sex-related penetrance risks. In ad-
dition to monogenic disorders caused by expansion of
repeat sequences (e.g., Huntington disease [Trottier et
al. 1994] fragile X syndrome [Loesch et al. 1995], and
congenital myotonic dystrophy [Lavedan et al. 1993])
and to defects resulting from differential contributions
of parental genomes (e.g., Angelman and Prader-Willi
syndromes [Nicholls 1993]), several complex diseases
with such a biased pattern have been reported—for ex-
ample, type 1 diabetes mellitus (Warram et al. 1984), in
which parent-of-origin effects have been reported at two
susceptibility loci, located in theMHC and in the insulin-
gene regulatory region (Vadheim et al. 1986; Julier et
al. 1991; Margaritte-Jeannin et al. 1995; Bui et al. 1996;
Noble et al. 1996); bipolar affective disorder (McMahon
et al. 1995); rheumatoid arthritis (Meyer et al. 1996);
and asthma and atopy (Daniels et al. 1996). On the basis
of maternal allelic distortion at several predisposing loci,
the penetrance of asthma and atopy has been proposed
as resulting from feto-maternal interactions (Daniels et
al. 1996). For MHC-linked coeliac disease, Petronzelli
et al. (1997) suggested that the parental sex influences
the risk to affected children that is conferred by theDR3-
bearing haplotypes, found their differential transmission
in affected but not in unaffected offspring, and men-
tioned overrepresentation of mothers among transmit-
ting parents. Parent-of-origin penetrance differences
have also been reported for inguinal hernia (Gong et al.
1994) and breast cancer (Lindblom et al. 1993).
The proposed hypothesis that the disease susceptibility
conferred by IGAD1 is mediated by anti-IgA antibodies
is supported by the observation of their transplacental
transport to the offspring who developed both IgAD and
anti-IgA antibodies early in life (Weemaes et al. 1982)
that were accompanied by T-cell defects (de Laat et al.
1991). These case reports led de Laat et al. (1991) to
suggest that IgAD with early-onset anti-IgA antibody
production may be a distinct entity. Such an etiological
mechanism is not unique, because a transplacental pas-
sage of maternal anti-Ro/anti-La antibodies can result
in permanent fetal conduction-system damage and con-
genital heart block in neonatal lupus erythematosus as-
sociated with maternal DR3 (Olah and Gee 1993). It
would be interesting to test this hypothesis in other
MHC-linked autoimmune diseases with reported paren-
tal effects in the penetrance and allele segregation.
The IgAD autoimmune component proposed in this
study is supported by earlier reports of a high prevalence
of antibodies against different autoantigens in IgAD and
the multireactivity of these antibodies (Goshen et al.
1989; Barka et al. 1995). Of 21 different autoantibodies,
16 were found in a significantly higher frequency in in-
dividuals with IgAD than in unaffected controls (Barka
et al. 1995). A higher prevalence of anti-IgA antibodies
was found in patients with IgADwho had either systemic
lupus erythematosus or rheumatoid arthritis, compared
with healthy subjects with IgAD (Petty et al. 1979).
IGAD1 Locus
Although the results of linkage analyses indicate a
maximum allele sharing just centromeric of the MHC,
the TDT clearly points to the proximal part of theMHC
region (table 1). In meiotic mapping of Mendelian dis-
eases, the underlying gene is present in the maximum-
sharing region delineated by the closest flanking recom-
binants. In complex traits, however, a lack of maximum
allele sharing at a predisposing locus, with a shift of this
maximum to an adjacent region, may reflect the fact
that one or more affected individuals does not carry the
disease-locus mutation. Therefore, IGAD1 is not likely
to be near D6S1583 but should be located more telo-
meric, closer toD6S273, the marker locus exhibiting the
most significant allelic associations and parental effects,
which maps to the MHC class III region betweenHSP70
and BAT2 (Martin et al. 1998). Since the allelic asso-
ciations with distal markers in class I and with those
telomeric to the MHC are weaker (table 1), IGAD1 is
likely to reside in the proximal half of the MHC, which
contains class II and class III genes.
The absence of IgAD among 43 Sardinian DR3 ho-
mozygotes—who share the class II haplotype, but not
the class III haplotype, with the disease-associatednorth-
ern European extended haplotype B8-DR3 (Cucca et al.
1998b)—appears to favor the class III region. This lo-
cation would correspond to that suggested by a recent
haplotype analysis in a single multicase family (Schroe-
der et al. 1998) and to that proposed earlier by Wilton
et al. (1985). However, screening of 24 B8-DR3 Scan-
dinavian homozygotes for serum IgA levels did not re-
veal any IgAD either (L. Hammarstro¨m, unpublished
data), perhaps suggesting that the relative risk conferred
by this haplotype may have been overestimated. The
prevalence of IgAD/CVID in DQB1*0201-DR3-B8-A1
homozygotes has been estimated to be as high as 13%
(Schroeder et al. 1998). Although the recombination rate
on the associated haplotype B8-DR3 is lower than av-
erage (Thomsen et al. 1994), and although the principle
of linkage-disequilibrium decline as a monotonic func-
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tion of the recombination fraction (v) appears to be vi-
olated in the IGAD1 candidate region (Klitz et al. 1995),
typing of our family material by recently defined micro-
satellite loci (Martin et al. 1998), as well as by MHC
specificities followed by linkage disequilibrium/haplo-
type analyses, may help us to define the locus further.
CVID versus IgAD
Separate TDT analyses of IgAD versus CVID seem to
suggest that IGAD1 confers susceptibility to IgAD rather
than to CVID, whereas loci responsible for the lack of
additional immunoglobulin classes in CVID are else-
where in the genome. This concurs with the observed
lack of significant parental effects in CVID. Less con-
vincing data supporting the role of the MHC in suscep-
tibility to CVID are consistent with a previous case-con-
trol study (Olerup et al. 1992), which showed that allelic
associations in both the class II region and the class III
region were much weaker in CVID than in IgAD. How-
ever, the number of available patients with CVID was
lower than the number of available patients with IgAD.
Furthermore, CVID is likely to be more genetically het-
erogeneous than IgAD, and the probability of misdi-
agnosis is higher (Spickett et al. 1997).
Candidate Molecules/Mutations at IGAD1
Because the IgAD/CVID phenotype is thought to be
limited to lymphocytes/macrophages, candidate mole-
cules defective at IGAD1 are likely to exhibit a narrow
expression, possibly confined to T-cells and/or antigen-
presenting cells. The failure of T-cells to respond to an-
tigens in CVID (Kondratenko et al. 1997), as well as the
presence of subtle T-cell abnormalities in IgAD (Horo-
witz and Hong 1975), point to a putative antigen-pre-
sentation defect, originally proposed to exist in a patient
with CVID (Eibl et al. 1982). This hypothesis is com-
patible with the observation that very low levels of IgA
and other isotypes can temporarily be induced in vivo
by lysosomotropic agents such as chloroquine (for re-
view, see Truedsson et al. 1995). This drug selectively
inhibits the capacity of splenic accessory cells to process
large antigens for T-cell activation and suppresses im-
mune responses to antigens requiring lysosomal pro-
cessing (Lee et al. 1982). The inhibition of antigen pre-
sentation (Ziegler and Unanue 1982) may be elicited by
other IgAD-inducing agents, such as gold salts, diphen-
ylhydantoin, or D-penicillamine; the latter drug is
known to lead to myasthenia gravis, systemic lupus er-
ythematosus, and, often, multiple autoimmune compli-
cations after a short treatment period (for review, see
Smith and Hammarstro¨m 1985). T-cell responses have
been implicated in the adverse effects caused by all these
agents (Gleichmann 1981; Schumann et al. 1990;
O’Donnell and Coleman 1992). CD4 cells from pa-
tients with CVID have reduced glutathione (Aukrust et
al. 1995), a major physiological reducing thiol, and its
decreased intracellular level has been linked to impaired
antigen presentation (Short et al. 1996). Although a re-
cent study did not reveal a defect in antigen presentation
by CVID B-cells and monocytes (Thon et al. 1997), the
possibility remains that it is indeed a defective crosstalk
between B-cell and T-cells that results in an impaired
isotype production in these PIDs.
Parent-of-origin penetrance differences, a maternal al-
lele-transmission bias at IGAD1, and the complex ge-
netics of the defect may suggest that the disease-predis-
posing mutation(s) can lie outside a gene coding
sequence. This location could be an altered DNA-bind-
ing target or a tandem repeat of a unique sequence,
which have been found to be either associated with or
contained within imprinted genes. HeritableDNA-meth-
ylation changes at CpG dinucleotides of several nucle-
otide-sequence motifs in the MHC have been shown to
alter binding of some DNA-binding proteins to their
recognition sequence (Zhang et al. 1990). A recent study
has indicated that b-like chains in the MHC class II
region have a CpG island over the most polymorphic
second exons, and promoter inactivation has been
shown to lead to methylation of the mouse class II Ab
CpG island (Macleod et al. 1998).
In conclusion, the present study provides evidence of
genetic linkage and population stratifica-
tion–independent allelic associations in IgAD/CVID, lo-
calizing the first PID polygene to a chromosomal region
by means of meiotic mapping. Observed parent-of-origin
penetrance differences in IgAD associated with allelic
segregation distortion at the MHC are proposed to be
caused by a maternal effect, which involves the produc-
tion of anti-IgA antibodies tentatively linked to IGAD1.
The identification of other susceptibility loci by genome
scanning (I. Vorˇechovsky´, unpublished data), some of
which may be involved in the regulation of serum IgA
levels in normal individuals (Wiltshire et al. 1998) or
reside on the X chromosome (Cucca et al. 1998a),
should lead to better understanding of the terminal
stages in lymphocyte differentiation and of PIDs.
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